Current Report Filing (8-k)
31 December 2022 - 01:47AM
Edgar (US Regulatory)
0001630212 false 0001630212 2022-12-29
2022-12-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
December 29, 2022
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-38728 |
|
47-1685128 |
(State
or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification
Number)
|
4400 Route 9 South,
Suite 3100,
Freehold,
New Jersey
07728
(Address of principal executive offices) (zip code)
646-762-4517
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425) |
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12) |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)) |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
☐ Emerging growth company
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbols |
|
Name
of each exchange on which registered |
Common Stock, $0.0001 par value per share |
|
AVCO |
|
The
Nasdaq Capital Market |
Item
5.07 Submission
of Matters to a Vote of Security Holders
Avalon GloboCare Corp. (the "Company") held its Annual Meeting on
December 29, 2022. Of the 99,984,439 shares of Common Stock
outstanding on November 15, 2022, the record date, 71,284,782
shares were represented at the Annual Meeting, in person or by
proxy, constituting a quorum. The proposals considered at the
Annual Meeting are described in detail in the Proxy Statement. The
proposals described below were voted upon at the Annual Meeting and
the number of votes cast with respect to each proposal was as set
forth below:
(1) Elect six directors until his successor is duly elected and
qualified, or until his earlier death, resignation or removal. The
six directors receiving the highest vote were appointed to the
board. The following Directors were elected to the board.
|
|
For |
|
|
Withheld |
|
Wenzhao “Daniel” Lu |
|
|
53,982,841 |
|
|
|
590,963 |
|
David Jin, MD, PhD |
|
|
54,000,145 |
|
|
|
573,659 |
|
Steven A. Sanders |
|
|
53,931,438 |
|
|
|
642,366 |
|
Wilbert J. Tauzin, II |
|
|
53,984,652 |
|
|
|
589,152 |
|
William B. Stilley, III |
|
|
53,939,369 |
|
|
|
634,435 |
|
Tevi Troy |
|
|
53,939,946 |
|
|
|
633,858 |
|
(2) Ratify the appointment of MARCUM LLP as the Company's
independent registered public accounting firm for the year ending
December 31, 2022. This matter was determined based on majority of
the shares cast.
For |
|
Against |
|
Abstain |
71,144,419 |
|
77,386 |
|
62,977 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
|
AVALON
GLOBOCARE CORP. |
|
|
Dated:
December 30, 2022 |
By: |
/s/ Luisa
Ingargiola |
|
|
Name: |
Luisa
Ingargiola |
|
|
Title: |
Chief
Financial Officer |
2
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2023 to Mar 2023
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2022 to Mar 2023